Paul Langerhans

Overview

Paul Langerhans (July 25, 1847 – July 20, 1888) was a German pathologist, physiologist, and biologist who, in his 1869 doctoral thesis at the University of Berlin, first described the clusters of cells within the pancreas that now bear his name — the islets of Langerhans. Although he did not know their function at the time, his careful histological description provided the anatomical foundation for the subsequent identification of insulin more than fifty years later.

Langerhans was a young medical student when he undertook a histological study of the pancreas under the supervision of Rudolf Virchow. Using novel staining techniques, he identified small, specially organized cell clusters distributed throughout the pancreatic tissue and distinct from the acinar cells responsible for digestive enzyme secretion. He noted their rich vascularity and unusual appearance but could not determine their function.

It was Edouard Laguesse, a French histologist, who in 1893 proposed that these islets were the source of an internal pancreatic secretion and named them "islets of Langerhans" in honor of the young German. The subsequent experiments of Minkowski and von Mering in 1889 had already shown that pancreatic removal produced diabetes, and the inference that the islets produced a diabetes-preventing factor became increasingly strong through the late nineteenth and early twentieth centuries, culminating in the Toronto insulin work.

Background

Langerhans was born in Berlin, the son of a physician. He studied medicine at Jena and Berlin and completed his doctoral thesis, "Beiträge zur mikroskopischen Anatomie der Bauchspeicheldrüse" ("Contributions to the Microscopic Anatomy of the Pancreas"), in 1869. He was only 22 years old.

His early career was cut short by tuberculosis, which he contracted in his mid-twenties. He moved to Madeira for the climate and continued to work on parasitology, skin anatomy, and comparative biology until his death at age 40. Among his other notable contributions was the 1868 discovery of the dendritic cells of the skin, now called Langerhans cells.

Key Contributions

• First description of the pancreatic islets (1869).
• Description of Langerhans cells of the epidermis (1868).
• Comparative histological studies of invertebrate and vertebrate anatomy.
• Contributions to early parasitology and dermatology during his years on Madeira.

Timeline

• 1847: Born in Berlin.
• 1868: Describes the dendritic cells of skin (Langerhans cells).
• 1869: Publishes doctoral thesis on pancreatic histology, describing the islets.
• Early 1870s: Begins medical practice; contracts tuberculosis.
• 1875: Moves to Madeira for health reasons.
• 1888: Dies on Madeira at age 40.
• 1893: Laguesse names the pancreatic islets after Langerhans.

Modern Relevance

The islets of Langerhans are now understood to contain several hormone-producing cell types: beta cells (insulin), alpha cells (glucagon), delta cells (somatostatin), PP cells (pancreatic polypeptide), and epsilon cells (ghrelin). Together they form a miniature endocrine organ whose coordinated function regulates carbohydrate, protein, and fat metabolism.

The clinical relevance of the islets is immense. Type 1 diabetes is an autoimmune destruction of beta cells; type 2 diabetes involves beta-cell dysfunction alongside insulin resistance; islet cell tumors (insulinomas, glucagonomas, somatostatinomas, gastrinomas) are distinct clinical entities. Islet transplantation — transferring isolated islets from donor pancreases to patients with type 1 diabetes — has become a specialized therapy building directly on Langerhans's nineteenth-century description. For related content, see banting-best-insulin.

Related Compounds

• Insulin
• Glucagon
• Somatostatin
• Pancreatic polypeptide
• Ghrelin